Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Rex Fang & Innovation Equity Premium Income ETF (FEPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Rex Fang & Innovation Equity Premium Income ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.51 (market cap $4.59B), while Rex Fang & Innovation Equity Premium Income ETF trades at $43.53 (market cap $746.48M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 6.1× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Rex Fang & Innovation Equity Premium Income ETF for 56 Days on average.
| DFTX | FEPI | |
|---|---|---|
Market Cap | $4.59B | $746.48M |
Volume | 2,103,937 | 334,337 |
Sector | Health | Income / Options Overlay |
52-Week High | $48.45 | $49.54 |
52-Week Low | $10.68 | $37.98 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $3.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.51, down 0.18% with a bullish technical signal from moving averages. The ETF employs a covered call strategy on concentrated AI and mega-cap tech holdings, generating high weekly distributions averaging $0.20-0.21. Recent articles highlight its 25% trailing yield but note capped upside potential and underperformance versus peers in total return during tech rallies.
The outlook balances high income generation against significant risk from tech concentration and volatility dependence. While the covered call strategy funds substantial dividends, it limits capital appreciation during market upswings. Key risks include drawdown vulnerability if tech stocks decline and competitive pressure from higher-performing income alternatives. Analyst sentiment remains cautious due to the trade-off between yield and total return potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →
